B R Prashantha Kumar (Prashantha Kumar Br, Prashantha Kumar B R)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

RSC advances

Antibiotics (Basel, Switzerland)

ACS chemical neuroscience

ACS omega

JSS College of Pharmacy, Mysuru

JSS College of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

JSS College of Pharmacy, Mysuru Mar 01 2003

India

Assistant Professor :: Pharmaceutical Chemistry

Education History

JSS College of Pharmacy Mar 01 2003

India

PHD :: Pharmaceutical Chemistry

Publications

Syed Faizan, Sirajunisa Talath, Adil Farooq Wali, Umme Hani, Nazima Haider, Subhankar P Mandal, B R Prashantha Kumar
Anticancer potential of novel symmetrical and asymmetrical dihydropyridines against breast cancer via EGFR inhibition: molecular design, synthesis, analysis and screening. RSC advances 14 (16) (2024)
Syed Faizan, Sirajunisa Talath, Adil Farooq Wali, Umme Hani, Nazima Haider, Subhankar P Mandal, B R Prashantha Kumar
Anticancer potential of novel symmetrical and asymmetrical dihydropyridines against breast cancer via EGFR inhibition: molecular design, synthesis, analysis and screening. RSC advances 14 (16) (2024)
Saleem Javid, Hissana Ather, Umme Hani, Ayesha Siddiqua, Shaik Mohammad Asif Ansari, Dhivya Shanmugarajan, Honnavalli Yogish Kumar, Rajaguru Arivuselvam, Madhusudan N Purohit, B R Prashantha Kumar
Discovery of Novel Myristic Acid Derivatives as N-Myristoyltransferase Inhibitors: Design, Synthesis, Analysis, Computational Studies and Antifungal Activity. Antibiotics (Basel, Switzerland) 12 (7) (2023)
Mahendra Gowdru Srinivasa, Revanasiddappa B C, Ashwini Prabhu, Vinitha Rani, Sudeep D Ghate, B R Prashantha Kumar
Development of novel thiazolidine-2,4-dione derivatives as PPAR-γ agonists through design, synthesis, computational docking, MD simulation, and comprehensive in vitro and in vivo evaluation. RSC medicinal chemistry 14 (11) (2023)
Prabitha Prabhakaran, Abhishek Nadig, Sahyadri M, Sunanda Tuladhar, Ruby Mariam Raju, Saravana Babu Chidambaram, Bettadaiah Bheemanakere Kempaiah, Nulgumnalli Manjunathaiah Raghavendra, B R Prashantha Kumar
Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson's Disease. ACS omega 8 (7) (2023)
Prabitha Prabhakaran, Abhishek Nadig, Sahyadri M, Sunanda Tuladhar, Ruby Mariam Raju, Saravana Babu Chidambaram, Bettadaiah Bheemanakere Kempaiah, Nulgumnalli Manjunathaiah Raghavendra, B R Prashantha Kumar
Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson's Disease. ACS omega 8 (7) (2023)
Rajaguru Arivuselvam, Ayed A Dera, Syed Parween Ali, Yasser Alraey, Ahmed Saif, Umme Hani, Sivaa Arumugam Ramakrishnan, Mohamed Sheik Tharik Abdul Azeeze, Raman Rajeshkumar, Aishwarya Susil, Haritha Harindranath, B R Prashantha Kumar
Isolation, Identification, and Antibacterial Properties of Prodigiosin, a Bioactive Product Produced by a New Serratia marcescens JSSCPM1 Strain: Exploring the Biosynthetic Gene Clusters of Serratia Species for Biological Applications. Antibiotics (Basel, Switzerland) 12 (9) (2023)
Subhankar Mandal, B R Prashantha Kumar, Md Tanjim Alam, Prem Prakash Tripathi, Bhavya Channappa
Novel Imidazole Phenoxyacetic Acids as Inhibitors of USP30 for Neuroprotection Implication via the Ubiquitin-Rho-110 Fluorometric Assay: Design, Synthesis, and In Silico and Biochemical Assays. ACS chemical neuroscience 13 (9) (2022)
Subhankar Mandal, Syed Faizan, Nulgumnalli Manjunathaiah Raghavendra, B R Prashantha Kumar
Molecular dynamics articulated multilevel virtual screening protocol to discover novel dual PPAR α/γ agonists for anti-diabetic and metabolic applications. Molecular diversity (2022)
Noor Fathima Anjum, Dhivya Shanmugarajan, Vasanth Kumar Shivaraju, Syed Faizan, Namburu Lalitha Naishima, B R Prashantha Kumar, Saleem Javid, Madhusudan N Purohit
Novel derivatives of eugenol as potent anti-inflammatory agents via PPARγ agonism: rational design, synthesis, analysis, PPARγ protein binding assay and computational studies. RSC advances 12 (26) (2022)
Prabitha P, Antony Justin, T Durai Ananda Kumar, Mithuna Chinaswamy, B R Prashantha Kumar
Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics. ACS chemical neuroscience 12 (13) (2021)
Dhivya Shanmugarajan, Prabitha P, B R Prashantha Kumar, B Suresh
Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets. RSC advances 10 (52) (2020)
Antony Justin, Subhankar Mandal, P Prabitha, S Dhivya, S Yuvaraj, Pradeep Kabadi, Satheesh John Sekhar, C H Sandhya, Ashish D Wadhwani, Selvaraj Divakar, Jeyabalan Jeyaram Bharathi, Priya Durai, B R Prashantha Kumar
Rational Design, Synthesis, and In Vitro Neuroprotective Evaluation of Novel Glitazones for PGC-1α Activation via PPAR-γ: a New Therapeutic Strategy for Neurodegenerative Disorders. Neurotoxicity research 37 (3) (2019)
Subhankar P Mandal, Aakriti Garg, P Prabitha, Ashish D Wadhwani, Laxmi Adhikary, B R Prashantha Kumar
Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies. Chemistry Central journal 12 (1) (2018)

B R Prashantha Kumar.css-eqlu8i{font-size:small;padding-left:4px;} (Prashantha Kumar Br, Prashantha Kumar B R)

Publication Activity (10 Years)

Top Topics

Top Venues

B R Prashantha Kumar (Prashantha Kumar Br, Prashantha Kumar B R)